Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese Pediatric H5N1 Vaccine Study
NCT01911754Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Aug 2013
- Primary completion
- Nov 2013
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (vero cell-derived), sponsored by Resilience Government Services. Started Aug 2013; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
Beyond the preview
Go deeper on NCT01911754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911754.